6MX8

Crystal structure of anaplastic lymphoma kinase (ALK) bound by Brigatinib

「5J7H」から置き換えられました

6MX8 の概要

• エントリーDOI: 10.2210/pdb6mx8/pdb
• 分子名称: ALK tyrosine kinase receptor, 5-chloro-N~4~-[2-(dimethylphosphoryl)phenyl]-N~2~-{2-methoxy-4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]phenyl}pyrimidine-2,4-diamine (3 entities in total)
• 機能のキーワード: alk kinase, brigatinib, tyrosine kinase, transferase
• 由来する生物種: Homo sapiens (Human)
• タンパク質・核酸の鎖数: 1
• 化学式量合計: 35073.80

構造登録者

Dougan, D.R.,Zhou, T. (登録日: 2018-10-30, 公開日: 2018-12-12, 最終更新日: 2024-03-13)

• 主引用文献: Huang, W.S.,Liu, S.,Zou, D.,Thomas, M.,Wang, Y.,Zhou, T.,Romero, J.,Kohlmann, A.,Li, F.,Qi, J.,Cai, L.,Dwight, T.A.,Xu, Y.,Xu, R.,Dodd, R.,Toms, A.,Parillon, L.,Lu, X.,Anjum, R.,Zhang, S.,Wang, F.,Keats, J.,Wardwell, S.D.,Ning, Y.,Xu, Q.,Moran, L.E.,Mohemmad, Q.K.,Jang, H.G.,Clackson, T.,Narasimhan, N.I.,Rivera, V.M.,Zhu, X.,Dalgarno, D.,Shakespeare, W.C.; Discovery of Brigatinib (AP26113), a Phosphine Oxide-Containing, Potent, Orally Active Inhibitor of Anaplastic Lymphoma Kinase.; J. Med. Chem., 59:4948-4964, 2016; PubMed: 27144831; DOI: 10.1021/acs.jmedchem.6b00306

実験手法

X-RAY DIFFRACTION (1.96 Å)